Cost-of-illness of scleroderma: The case for rare diseases

Seminars in Arthritis and Rheumatism

Volumn 27, Issue 2, 1997, Pages 73-84

  Wilson, L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Connective tissue disease; Cost; Cost effectiveness; Cost of illness; Rare disease; Scleroderma; Systemic sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONNECTIVE TISSUE DISEASE; COST OF ILLNESS; FEMALE; HEALTH CARE COST; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS; UNITED STATES;

EID: 0030815769     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(97)80008-X     Document Type: Article

References (37)

1. Hartunian N.S. Smart C.N. Thompson M.S. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis AJPH 70 1980 1249 1260
2. Rice D.P. MacKenzie E. Cost of Injury in the United States: A Report to Congress 1989 Institute for Health & Aging, University of California and Injury Prevention Center, The Johns Hopkins University San Francisco
3. Medsger T.A. Jr Epidemiology of systemic sclerosis Clin Dermatol 12 1993 207 216
4. Bruckdorfer K.R. Hillary J.B. Bunce T. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis Arthritis Rheum 38 1995 1060 1067
5. White B. Bauer E.A. Goldsmith L.A. Guidelines for clinical trials in systemic sclerosis (scleroderma) Arthritis Rheum 38 1995 351 360
6. Steen V.D. Medsgar T.A. Jr Epidemiology and natural history of systemic sclerosis Rheum Dis Clin North Am 16 1990 1 10
7. Abu-Shakra M. Lee P. Mortality in systemic sclerosis: a comparison with the general population J Rheumatol 22 1995 2100 2101
8. Altman R.D. Medsger T.A. Bloch D.A. Predictors of survival in systemic sclerosis (scleroderma) Arthritis Rheum 34 1991 403 413
9. Hochberg M.C. Lopez-Acuna D. Gittelsohn A.M. Mortality from systemic sclerosis (scleroderma) in the United States, 1969–1977 Black C.M. Myers A.R. Systemic sclerosis (scleroderma) 1985 Gower New York 61 69
10. Steen V.D. Conte C. Owens G.R. Severe restrictive lung disease in systemic sclerosis Arthritis Rheum 37 1994 1283 1289
11. Valentine G. Classification of systemic sclerosis Clin Dermatol 12 1994 217 223
12. Fries J.F. Hochberg M.C. Medsger T.A. Jr Criteria for rheumatic disease Arthritis Rheum 37 1994 454 462
13. Sillman A. Hochberg M. Epidemiology of rheumatic disease: scleroderma 1993 Oxford Medical Press Oxford, England
14. Steen V.D. Epidemiology of rheumatic disease: systemic sclerosis Rheum Dis Clin North Am 16 1990 641 654
15. Hodgson T.A. Meiners M.R. Cost-of-illness methodology: a guide to current practices and procedures Milbank Mem Fund Q 60 1982 429 463
16. Medsgar T.A. Jr Epidemiology of systemic sclerosis Clin Dermatol 12 1994 207 216
17. Maricq H.R. Weinrich M.C. Keil J.E. Prevalence of scleroderma spectrum disorders in the general population of S. Carolina Arthritis Rheum 32 1989 998 1006
18. Michet C.J. WcKenna C.H. Elveback L.R. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979 Mayo Clin Proc 60 1985 105 110
19. Series 13, No. 118 Vital and Health Statistics CDC National Center for Health Statistics Detailed diagnoses and procedures, National Hospital Discharge Survey PHS Pub. No. 94-1779 1992 U.S. Dept Health and Human Services Hyattsville, MD
20. Health Services Cost Review Commission Inpatient Case-mix Data Base 1994 St Paul Computer Center, Inc Glen Burnie, MD
21. Wolfe F. Fries J.F. ARAMIS today: moving toward internationally distributed databank systems for follow-up studies Clin Rheumatol 6 Suppl 2 1987 93 102
22. American Hospital Association LOS: Length of stay by diagnosis and operation 1990 HCIA
23. Fries J.F. Spitz P. Kraines R.G. Measurement of patient outcome in arthritis Arthritis Rheum 23 1980 146 152
24. Fries J.F. Spitz P.W. Young D.Y. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales J Rheumatol 9 1982 790 793
25. Wolfe F. Kleinheksel S.M. Cathey M.A. The clinical value of the Stanford health assessment questionnaire functional disability index in patients with rheumatoid arthritis J Rheumatol 15 1988 1480 1488
26. Miller T.R. Willingness to pay: Pandora's box or palliative for liability problems J Policy Analysis Management 7 1988 363 367
27. U.S. Bureau of Census Labor Force Employment and Earnings, Statistical Abstracts of the United States 1995 430
28. Peskin J. The value of household work in the 1980's 1984 Congressional Budget Office Washington, DC
29. Table 43 Bureau of Labor Statistics Handbook of labor statistics. Bulletin 2340 1996 81
30. Steen V.D. Lanz J.K. Conte C. Therapy for severe interstitial lung disease in systemic sclerosis Arthritis Rheum 37 1994 1290 1296
31. Sillman A.J. Mortality from scleroderma in England and Wales 1968—1985 Ann Rheum Dis 50 1991 95 96
32. Hay J.W. Hay A.R. Inflammatory bowel disease: Costs-of-illness J Clin Gastroenterol 14 1992 309 317
33. Gorelick P.B. Stroke prevention Arch Neurol 52 1995 347 355
34. Suppl 1 Dobkin B. The economic impact of stroke Neurology 45 2 1995 S6 S9
35. Ernst R.L. Hay J.W. The US economic and social costs of Alzheimer's disease revisited Am J Public Health 84 1994 1261 1264
36. Rice D.P. Fox P.J. Max W. The economic burden of Alzheimer's disease care Health Affairs 12 1993 164 176
37. Yelin E. Callahan L.F. The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups Arthritis Rheum 38 1995 1351 1362